Search Results 931-940 of 16981 for pharmacogenetics

  1. Clinical trials - Oncology (Medical)

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  2. A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    The purpose of this study is to examine the safety and efficacy of Ibrutinib administered in combination with bendamustine and rituximab in patients with ...

  3. Publications - Kathryn V. Pruden, M.D. - Mayo Clinic

    Kwon J, Pruden K, Mohseni MM. Rapidly developing, large pyogenic liver abscesses in the setting of pancreatic cancer. Proc (Bayl Univ Med Cent).

  4. Faculty - Department of Biochemistry and Molecular Biology - Mayo Clinic Research

    To learn more about the research interests of individual faculty members in the Department of Biochemistry and Molecular Biology, including their location, ...

  5. A Study to Evaluate Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of CD34+ cell intracoronary injections for treating coronary endothelial dysfunction (CED) ...

  6. Functional Outcome in Patients with Subarachnoid Hemorrhage - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    The purpose of this study is to determine the effectiveness of MB-CART2019.1 cells administered following a conditioning lymphodepletion regimen in diffuse ...

  8. Publications - Timothy D. Wiltshire, Ph.D. - Mayo Clinic

    Krull AA, DiGuardo MA, Deeds MC, Skaer CA, Soiney KA, Wadewitz M, Wiltshire TD, Gastineau DA, Dietz AB, Jacob EK. Fellowship training for cellular therapy ...

  9. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Pediatrics Clinical Trials - Medical Professionals

    The primary purpose of this study is to investigate the cytokine responses of blood ILC2s from preterm children by collecting peripheral blood at age 5-10 ...